| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |